News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Batu Biologics Reaches 50% Of Crowdfunding Goal


7/8/2014 11:20:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today that the company successfully rose over 50% of its crowdfunding target to assist in completion of preclinical studies to support the FDA submission of its novel cancer vaccine, ValloVax™. On June 18th, 2014 Batu Biologics announced the launch of its Indiegogo campaign seeking to raise $100,000, which can be viewed online at the following link: https://www.indiegogo.com/projects/emerging-lung-cancer-vaccine-targets-tumor-blood-vessels-introducing-vallovax

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES